Merck Receives New Vaccine Vaxneuvance™ Approval

7/27/21 The FDA approved last week this newest conjugate vaccine pneumococcal 15-valent, Vaxneuvance™ manufactured by Merck. Now, finally more vaccine options are available for the prevention of invasive pneumoccocal disease caused by Streptococcus...

Prevnar 20 Wins FDA Approval!

6/9/21 Pfizer’s conjugated pneumonia vaccine #PCV20 just approved!  Physicians and medical groups needing access to discount pricing on Pfizer vaccines as well as Merck, Sanofi Pasteur and AstraZeneca may do so through a free MPPG membership. Join MPPG...

Special Vaxelis Pricing is Available

5/4/2021 The much-anticipated DTaP-IPV-Hib-HepB vaccine, Vaxelis will begin shipping in June. Not only will this new combination vaccine reduce injections for infants, it may simultaneously be more convenient for healthcare providers.  Vaxelis requires no...